Predictors of screening for cervical and colorectal cancer in women 50–65 years old in a multi-ethnic population
Autor: | Mas Jimbo, Sherri Sheinfeld Gorin, Melissa A. Plegue, Minal R. Patel, Ananda Sen, Diane M. Harper, Ken Resnicow |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
aOR
adjusted odds ratio FOBT fecal occult blood test Epidemiology Colorectal cancer BMI body mass index Population Ethnic group 030209 endocrinology & metabolism Cervical cancer screening Colorectal cancer screening 03 medical and health sciences 0302 clinical medicine Females Cancer screening Health care medicine USPSTF United States Preventive Services Task Force 030212 general & internal medicine COVID-19 coronavirus -19 or SARS-CoV-2 – severe acute respiratory syndrome coronavirus 2 education Multinomial logistic regression education.field_of_study SE standard error business.industry Public Health Environmental and Occupational Health Cancer Regular Article medicine.disease Middle Eastern-North American (MENA) ethnicity FDA Food and Drug Administration of the United States FIT fecal immunochemical test OR odds ratio MT sDNA test – multitarget stool DNA test - Cologuard® CRC colorectal cancer FIT DNA multitarget stool DNA test MENA Middle Eastern/North African Medicine business 50–65 years old Demography |
Zdroj: | Preventive Medicine Reports, Vol 22, Iss, Pp 101375-(2021) Preventive Medicine Reports |
ISSN: | 2211-3355 |
Popis: | Highlights • Middle Eastern/North African (MENA) women in the US have the lowest up-to-date screening rate of colorectal and cervical cancer of all races/ethnicities at 18%. • Any chronic health condition doubles the likelihood of having both below the belt screens compared to neither screen. • Women without insurance are more likely to only have cervical cancer compared to both colorectal and cervical cancer up-to-date screens. • 54% of women 50–65 years old are up-to-date with both colorectal and cervical cancer screening. Middle Eastern/North Africa (MENA) women are often not identified in cancer screening studies. The aim of this study was to determine the rates and predictors of cervical and colorectal cancer (CRC) screening for women 50–65 years of three race/ethnicities. White, black and MENA women of Southeast Michigan were surveyed once in 2019 for demographics, health care barriers, chronic diseases, and cancer screening updates using in-person, telephone, and online methods. Descriptive statistics and multivariate multinomial logistic regression were used to predict up-to-date colorectal cancer and cervical cancer screening. All analyses were adjusted by local population weights for comparability and generalizability. 394 women participated with 54% up-to-date on both screenings, 21% for cervical cancer screening alone, and 12% for CRC alone. Women more likely to be up-to-date for only cervical cancer screening compared to both cancer screens are younger (aOR 0.83 (95% CI 0.76, 0.92), are of MENA descent (7.97 (2.46, 25.76) and have no insurance (9.41 (1.07, 82.92). There are no predictors for women being up-to-date for CRC screening alone compared to both screens. Among women 50–65 years old, being up-to-date in cervical cancer screening is unrelated to being up-to-date for CRC screening. Compared to Healthy People 2020, there are significant gaps in cervical and CRC screening among women 50–65 years old of all races, but particularly among women of MENA descent who are even less likely to have CRC screening than cervical cancer screening. |
Databáze: | OpenAIRE |
Externí odkaz: |